Delivery Order SPE2DB20D1110-SPE2DB25FJ78H
Award Date
11/22/24
Potential Completion Date
11/25/24
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,908.68, is for the delivery of 4,566,615,580 units of 4 mg Ondansetron HCL tablets. The contract is a firm fixed-price delivery order, without any set-aside designation, and has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,999.00, is a Delivery Order for the supply of 4,566,304,145 units of Ondansetron HCL 4 mg Tablets. This Firm Fixed Price contract has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,707.55 firm fixed price delivery order is for the supply of 4,566,197,426 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,313.20 firm fixed-price delivery order is for the supply of 4,566,142,417 units of Ondansetron HCl 4 mg tablets. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,830.41, is for the delivery of 4,566,407,695 units of Ondansetron HCL 4 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of November 13, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,385.89 firm fixed price delivery order is for the supply of 4 mg Ondansetron HCL tablets. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $4,733.59 for the supply of 4,566,262,385 units of Ondansetron HCL 8 mg tablets. The contract has an ultimate completion date of October 30, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,119.64 firm fixed-price delivery order is for the supply of 4,566,134 units of the medication Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract worth $1,222.69 for the supply of 4,564,095,638 units of Ondansetron HCL 4 MG tablets. The contract has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation, is the prime contractor. This delivery order is part...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,789.99 firm fixed-price delivery order is for the supply of 4,565,700 units of Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of September 6, 2024 and was awarded on September 5, 2024. The contract was not designated with a set-aside requirement, indicating open competition....